SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-013796
Filing Date
2018-11-06
Accepted
2018-11-06 16:57:53
Documents
3
Period of Report
2018-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kvibativacquisitionannou.htm 8-K 30738
2 PRESS RELEASE VIBATIV vibativannouncementpressre.htm EX-99.1 20927
3 cumberlanda11.gif GRAPHIC 10657
  Complete submission text file 0001628280-18-013796.txt   67597
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 181163744
SIC: 2834 Pharmaceutical Preparations